Lawsuit charges weigh on Bayer profits again

February 28, 2013

(AP)—Charges for lawsuits over its birth control pills weighed on Bayer AG's earnings once again during the fourth quarter of 2012.

The German company said Thursday it made a of €374 million ($490 million) during the period, compared with €397 million the previous year.

The company booked €455 million in charges during the quarter due to current or anticipated lawsuits in the United States over claims of injuries from blood clots associated with its .

The profit fall masked a 7.3 percent rise in sales to €9.86 billion.

For the full year, net income declined 1 percent to €2.45 billion while sales rose 8.8 percent to €39.8 billion.

Aside from the problems with the contraceptives, the company said its business was doing well, with sales rising across the three basic divisions: prescription and over-the-counter drugs, farm chemicals and seeds, and such as polyurethanes, adhesives and coatings.

Excluding the lawsuit expenses, earnings before interest, taxes and other financial factors rose 9 percent to €8.24 billion.

Bayer has said it will raise its dividend for 2012 to €1.90 per share from €1.65 amid optimism over the coming year. It forecast a percentage increase in operating earnings in the mid-single digit range.

Bayer shares rose 2.6 percent to €75.71 in morning trading in Europe.

Explore further: J&J Q3 net income drops 7 percent on higher costs


Related Stories

J&J Q3 net income drops 7 percent on higher costs

October 16, 2012

Johnson & Johnson's third-quarter profit fell 7 percent as increased research and production costs offset higher sales for its medicines and medical devices and new revenue from its biggest acquisition ever.

Amgen 4Q profit drops 16 pct. on higher spending

January 23, 2013

Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results ...

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.